EDGAR Filing Documents for 0001279569-15-002185

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001279569-15-002185

Filing Date

2015-11-12

Accepted

2015-11-12 08:17:17

Documents

Period of Report

2015-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	v424228_10q.htm	10-Q	830935
2	EXHIBIT 2.1	v424228_ex2-1.htm	EX-2.1	233358
3	EXHIBIT 2.2	v424228_ex2-2.htm	EX-2.2	26542
4	EXHIBIT 10.11	v424228_ex10-11.htm	EX-10.11	64799
5	EXHIBIT 10.12	v424228_ex10-12.htm	EX-10.12	49379
6	EXHIBIT 10.13	v424228_ex10-13.htm	EX-10.13	48806
7	EXHIBIT 10.14	v424228_ex10-14.htm	EX-10.14	49431
8	EXHIBIT 10.15	v424228_ex10-15.htm	EX-10.15	34485
9	EXHIBIT 31.1	v424228_ex31-1.htm	EX-31.1	7445
10	EXHIBIT 31.2	v424228_ex31-2.htm	EX-31.2	7260
11	EXHIBIT 32.1	v424228_ex32-1.htm	EX-32.1	5589
	Complete submission text file	0001279569-15-002185.txt		1359018

Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9

Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449

Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)